The importance of FLT3 mutational analysis in acute myeloid leukemia.

about

Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation.

P2860

Q52576433-463F66FA-675C-4EF5-A7A3-51F557429301

P2860

The importance of FLT3 mutational analysis in acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q48255430

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The importance of FLT3 mutational analysis in acute myeloid leukemia.

@en

The importance of FLT3 mutational analysis in acute myeloid leukemia.

@nl

type

Item

label

The importance of FLT3 mutational analysis in acute myeloid leukemia.

@en

The importance of FLT3 mutational analysis in acute myeloid leukemia.

@nl

prefLabel

The importance of FLT3 mutational analysis in acute myeloid leukemia.

@en

The importance of FLT3 mutational analysis in acute myeloid leukemia.

@nl

P1476

The importance of FLT3 mutational analysis in acute myeloid leukemia

@en

P2093

Mrinal M Patnaik

http://www.w3.org/2001/XMLSchema#string

P2860

The role of FLT3 in haematopoietic malignancies

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.

Prognostic relevance of FLT3-TKD mutations in AML: the combination matters--an analysis of 3082 patients.

Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

FMS-like tyrosine kinase 3-internal tandem duplication tyrosine kinase inhibitors display a nonoverlapping profile of resistance mutations in vitro.

Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3.

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.

Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITD

P304

2273-2286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428194.2017.1399312

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mrinal M Patnaik

P577

2017-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29164965

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

The importance of FLT3 mutational analysis in acute myeloid leukemia.

about

P2860

P2860

The importance of FLT3 mutational analysis in acute myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921